A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus

NCT03449433 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: LY900014
DRUG: Insulin Lispro
DRUG: Insulin Aspart
DRUG: Insulin Aspart

Sponsor

Eli Lilly and Company